Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

TYRA - Tyra Biosciences Inc


IEX Last Trade
22.785
0.655   2.875%

Share volume: 404,494
Last Updated: Fri 30 Aug 2024 09:59:45 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$22.13
0.66
2.96%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
3.17%
1 Month
5.52%
3 Months
44.51%
6 Months
14.37%
1 Year
47.03%
2 Year
213.28%
Key data
Stock price
$22.78
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$10.38 - $24.25
52 WEEK CHANGE
$0.52
MARKET CAP 
1.202 B
YIELD 
N/A
SHARES OUTSTANDING 
52.806 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
1.73
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$167,467
AVERAGE 30 VOLUME 
$173,494
Company detail
CEO:
Region: US
Website: tyra.bio
Employees: 34
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

tyra biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.

Recent news